General Geek Episode 05.29.2015
This week on Altered Geek the guys talk about the latest Super Hero in Suicide Squad, E3, Arkham Knight, Mass Effect and other thoughts. Hope everyone listened to the last episode and enjoys this weeks as well. Thank you again to all who responded last week and we hope you join in the conversation this week as well. All this and more on this week’s AGU! We hope you continue to enjoy the episodes and please feel free to respond to any and all feedback methods. We will read and reply on the show. Topic suggestions also welcome. So get Altered, Get Geeky with the Altered Geeks.
All this and more on this week’s AGU! We hope you continue to enjoy the episodes and please feel free to respond to any and all feedback methods. We will read and reply on the show. Topic suggestions also welcome. So get Altered, Get Geeky with the Altered Geeks.
(NEW) Question of the Night:
Send us any comments you’d like! We plan to do a comment Q&A episode in the future.How do you feel about DLC and Games Pricing Strategies?
Feedback:
Voicemail Line: 502-526-5821
Email: feedback@geekcastradio.com
Twitter: @GeekCastRadio@ Hashtag #AlteredGeek
Facebook: GeekCast Radio Network
Geeks:
Steve “Megatron” Phillips
Mike “Boothninja” Powers
Mike The Birdman” Dodd
Subscribe to get the latest posts sent to your email.
Tagged as:
Altered Geek creative Geek geek culture geeks geeky Podcast podcast machine podcast machines podcasters podcasting
About the author call_made
Co-Creator @GeekCastRadio | Creator @AlteredGeek | Voice Actor | Podcaster, Husband | Father | Web/Graphic Design | A/V Editor | Geek of Games, Tech, Film, TV.
Use code GCRN at
The GeekCast Radio Network™ is a geek media organization dedicated to reviewing, analyzing and geeking out to the greatest parts of pop culture from the past, the present and the future. Our motto and mission is simple, we want to “Unleash the Geek in YOU!”™
Experience the Awesome Limited Edition Content From The GeekCast Radio Network
Copyright © 2009-2024 GeekCast Radio Network, LLC | GCRN™ | All Rights Reserved.
Session expired
Please log in again. The login page will open in a new tab. After logging in you can close it and return to this page.
Be the first to leave a comment